Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

SHE:300357 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash & Equivalents	888.72	797.22	1,119	1,171	840.69	649.99
Short-Term Investments	107.38	74.58	-	-	-	-
Trading Asset Securities	456.98	560.23	196.09	117.39	295.05	370.93
Cash & Short-Term Investments	1,453	1,432	1,315	1,289	1,136	1,021
Cash Growth	6.60%	8.91%	2.03%	13.47%	11.25%	14.62%
Accounts Receivable	285.26	242.93	251.04	202.92	254.31	238.12
Other Receivables	5.27	-	-	-	19.81	11.13
Receivables	290.53	242.93	251.04	202.92	274.12	249.26
Inventory	52.78	54.76	57.73	59.04	48.41	53.75
Other Current Assets	10.51	31.53	27.78	19.17	18.86	17.58
Total Current Assets	1,807	1,761	1,651	1,570	1,477	1,342
Property, Plant & Equipment	782.73	842.85	780.09	704.84	444.61	301.62
Long-Term Investments	321.58	108.32	77.94	74.21	78.4	83.35
Other Intangible Assets	123.05	149.46	162.79	161.38	139.67	94
Long-Term Deferred Tax Assets	6.05	5.58	5.6	5.03	4.87	5.81
Long-Term Deferred Charges	31.17	26.31	25.27	34.38	53.2	86.05
Other Long-Term Assets	6.57	3.64	5.94	12.42	-	19.63
Total Assets	3,078	2,897	2,709	2,562	2,198	1,932

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Accounts Payable	51.96	31.41	47.77	7.99	7.68	5.08
Accrued Expenses	34.31	37.27	35.13	33.57	29.89	35.54
Short-Term Debt	5	5	12.63	34.39	-	-
Current Portion of Leases	4.43	4.08	5.03	6.8	3.98	5.86
Current Income Taxes Payable	14.55	1.98	10.56	9.26	26.08	50.32
Current Unearned Revenue	0.6	0.53	0.51	0.38	0.42	0.42
Other Current Liabilities	86.8	64.3	70.95	84.64	34.71	10.78
Total Current Liabilities	197.66	144.57	182.58	177.04	102.75	108
Long-Term Leases	8.86	9.32	7.93	21.26	12.28	1.95
Long-Term Unearned Revenue	30.76	31.74	33.53	30.93	27.43	24.91
Long-Term Deferred Tax Liabilities	0.03	0.03	0.17	0.2	0.08	0.5
Other Long-Term Liabilities	-	-	26.08	29.03	28.22	-
Total Liabilities	237.3	185.67	250.3	258.46	170.76	135.36

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Common Stock	523.58	523.58	523.58	523.58	523.58	523.58
Additional Paid-In Capital	128.19	128.19	128.19	128.19	128.19	128.19
Retained Earnings	2,103	1,968	1,702	1,533	1,328	1,084
Comprehensive Income & Other	0.02	0.03	0.04	0.03	0.03	0
Total Common Equity	2,754	2,619	2,354	2,185	1,980	1,736
Minority Interest	86.39	92.27	105.12	118.61	47.49	60.54
Shareholders' Equity	2,841	2,712	2,459	2,304	2,027	1,797
Total Liabilities & Equity	3,078	2,897	2,709	2,562	2,198	1,932

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Total Debt	18.29	18.41	25.59	62.44	16.26	7.81
Net Cash (Debt)	1,435	1,414	1,289	1,226	1,119	1,013
Net Cash Growth	6.89%	9.64%	5.14%	9.54%	10.50%	13.74%
Net Cash Per Share	2.74	2.70	2.46	2.34	2.14	1.93
Filing Date Shares Outstanding	523.58	523.58	523.58	523.58	523.58	523.58
Total Common Shares Outstanding	523.58	523.58	523.58	523.58	523.58	523.58
Working Capital	1,609	1,617	1,469	1,393	1,374	1,234
Book Value Per Share	5.26	5.00	4.50	4.17	3.78	3.32
Tangible Book Value	2,631	2,470	2,191	2,024	1,840	1,642
Tangible Book Value Per Share	5.03	4.72	4.18	3.87	3.51	3.14
Buildings	701.43	638.01	428.52	423.31	175.67	137.89
Machinery	166.98	168.95	135.42	115.99	95.51	77.11
Construction In Progress	72.22	175.46	323.16	227.86	226.24	140.33

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error